Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Intellia Therapeutics (NTLA) Return on Assets (2016 - 2025)

Intellia Therapeutics (NTLA) has disclosed Return on Assets for 10 consecutive years, with 0.47% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 5.0% to 0.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.47%, a 5.0% decrease, with the full-year FY2025 number at 0.41%, down 1.0% from a year prior.
  • Return on Assets was 0.47% for Q4 2025 at Intellia Therapeutics, up from 0.49% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.2% in Q4 2021 to a low of 0.5% in Q2 2025.
  • A 5-year average of 0.35% and a median of 0.35% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: rose 12bps in 2021, then decreased -16bps in 2022.
  • Intellia Therapeutics' Return on Assets stood at 0.2% in 2021, then plummeted by -70bps to 0.35% in 2022, then fell by -6bps to 0.37% in 2023, then dropped by -12bps to 0.41% in 2024, then dropped by -13bps to 0.47% in 2025.
  • Per Business Quant, the three most recent readings for NTLA's Return on Assets are 0.47% (Q4 2025), 0.49% (Q3 2025), and 0.5% (Q2 2025).